Abstract

TUBB4A-associated disorder is a rare condition affecting the central nervous system. It displays a wide phenotypic spectrum, ranging from isolated late-onset torsion dystonia to a severe early-onset disease with developmental delay, neurological deficits, and atrophy of the basal ganglia and cerebellum, therefore complicating variant interpretation and phenotype prediction in patients carrying TUBB4A variants. We applied entropy-based normal mode analysis (NMA) to investigate genotype–phenotype correlations in TUBB4A-releated disease and to develop an in-silico approach to assist in variant interpretation and phenotype prediction in this disorder. Variants included in our analysis were those reported prior to the conclusion of data collection for this study in October 2019. All TUBB4A pathogenic missense variants reported in ClinVar and Pubmed, for which associated clinical information was available, and all benign/likely benign TUBB4A missense variants reported in ClinVar, were included in the analysis. Pathogenic variants were divided into five phenotypic subgroups. In-silico point mutagenesis in the wild-type modeled protein structure was performed for each variant. Wild-type and mutated structures were analyzed by coarse-grained NMA to quantify protein stability as entropy difference value (ΔG) for each variant. Pairwise ΔG differences between all variant pairs in each structural cluster were calculated and clustered into dendrograms. Our search yielded 41 TUBB4A pathogenic variants in 126 patients, divided into 11 partially overlapping structural clusters across the TUBB4A protein. ΔG-based cluster analysis of the NMA results revealed a continuum of genotype–phenotype correlation across each structural cluster, as well as in transition areas of partially overlapping structural clusters. Benign/likely benign variants were integrated into the genotype–phenotype continuum as expected and were clearly separated from pathogenic variants. We conclude that our results support the incorporation of the NMA-based approach used in this study in the interpretation of variant pathogenicity and phenotype prediction in TUBB4A-related disease. Moreover, our results suggest that NMA may be of value in variant interpretation in additional monogenic conditions.

Highlights

  • TUBB4A-associated disorder is a rare condition affecting the central nervous system

  • The ones associated with heterozygous pathogenic variants in TUBB4A demonstrate a broad phenotypic spectrum, including primary dystonia (DYT4; Autosomal dominant torsion dystonia-4; MIM#128101), isolated hypomyelination, hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC; Hypomyelinating leukodystrophy 6; MIM#612438), as well as early infantile ­encephalopathy[2]

  • We demonstrate the applicability of an entropy-based in-silico normal mode analysis (NMA) tool in the investigation of genotype–phenotype correlation and its potential use in variant interpretation and phenotype prediction in TUBB4A-related disease

Read more

Summary

Introduction

TUBB4A-associated disorder is a rare condition affecting the central nervous system. It displays a wide phenotypic spectrum, ranging from isolated late-onset torsion dystonia to a severe earlyonset disease with developmental delay, neurological deficits, and atrophy of the basal ganglia and cerebellum, complicating variant interpretation and phenotype prediction in patients carrying TUBB4A variants. We applied entropy-based normal mode analysis (NMA) to investigate genotype–phenotype correlations in TUBB4A-releated disease and to develop an in-silico approach to assist in variant interpretation and phenotype prediction in this disorder. Hypomyelinating leukodystrophies comprise a heterogeneous group of hereditary disorders, characterized by abnormal myelin development and typical brain MRI f­indings[1,2] Of these disorders, the ones associated with heterozygous pathogenic variants in TUBB4A demonstrate a broad phenotypic spectrum, including primary dystonia (DYT4; Autosomal dominant torsion dystonia-4; MIM#128101), isolated hypomyelination, hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC; Hypomyelinating leukodystrophy 6; MIM#612438), as well as early infantile ­encephalopathy[2]. We utilize an in-silico approach using NMA to investigate the effect of disease-associated TUBB4A missense variants on the encoded protein and their associated phenotype. This approach can be used in the classification of known missense variants and possibly predict the effect and phenotype of new variants of uncertain significance (VUS)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call